Dec 28, 2012
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.44 to $0.04.
The split itself did not change the total investment value.
Oncotelic Therapeutics, Inc. (OTLC) trades on the Other OTC in the Biotechnology industry.
Oncotelic Therapeutics, Inc. company overviewThe latest split shown was on December 28, 2012. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
This history records 2 reverse splits between February 23, 2011 and December 28, 2012.